0 CHECKOUT

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review

  • ID: 1322358
  • July 2016
  • 63 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abiomed, Inc.
  • Bayer HealthCare AG
  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche Ltd.
  • Jarvik Heart, Inc.
  • Medtronic plc
  • MORE

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abiomed, Inc.
  • Bayer HealthCare AG
  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche Ltd.
  • Jarvik Heart, Inc.
  • Medtronic plc
  • MORE

List of Tables

List of Figures

Section 1 - About the Company

Terumo Corporation - Key Facts

Terumo Corporation - Key Employees

Terumo Corporation - Key Operational Employees

Terumo Corporation - Major Products and Services

Terumo Corporation - Medical Equipment Pipeline Products Data

Terumo Corporation Pipeline Products by Equipment Type

Terumo Corporation Pipeline Products by Development Stage

Terumo Corporation - History

Terumo Corporation - Company Statement

Terumo Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Terumo Corporation - Business Description

Business Description - Blood Transfusion Products

Blood Transfusion Products - Overview

Blood Transfusion Products - Financials

Business Description - Cardiac and Vascular Products

Cardiac and Vascular Products - Overview

Cardiac and Vascular Products - Financials

Business Description - General Hospital Products

General Hospital Products - Overview

General Hospital Products - Financials

Terumo Corporation - Corporate Strategy

Terumo Corporation - SWOT Analysis

SWOT Analysis - Overview

Terumo Corporation - Strengths

Strength - Improving Financial Position

Strength - Cardiac and Vascular Franchise

Strength - Strong Presence in International Markets

Terumo Corporation - Weaknesses

Weakness - Product Safety Concerns

Weakness - Substantial Debt

Terumo Corporation - Opportunities

Opportunity - The US FDA 510(k) Clearances

Opportunity - Increasing Cardiovascular Diseases

Opportunity - Strategic Initiatives

Terumo Corporation - Threats

Threat - Rise in Raw Material Prices

Threat - Intense Competition

Threat - Rapid Technological Changes

Threat - Stringent Government Regulations

Terumo Corporation - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Terumo Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016

Terumo Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Terumo Corporation, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 10, 2016: FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility

Mar 02, 2016: NICE recommends new sickle cell treatment device that could save the NHS millions

Sep 02, 2015: Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare

Jul 01, 2015: OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo

Jun 01, 2015: MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo

Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant

Apr 06, 2015: Terumo and Olympus Expand Interventional System Business Partnership

Apr 02, 2015: Terumo announces CE mark approvals for LIFEPEARL and HYDROPEARL microspheres

Mar 19, 2015: Scientists at Nelson Laboratories Discover Extractable Positive Control for In Vitro Skin Irritation Testing of Medical Devices

Feb 12, 2015: Terumo Establishes a New RD Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Terumo Corporation, Key Facts

Terumo Corporation, Key Employees

Terumo Corporation, Key Operational Employees

Terumo Corporation, Major Products and Services

Terumo Corporation Pipeline Products by Equipment Type

Terumo Corporation Number of Pipeline Products by Development Stage

Terumo Corporation Pipeline Products Summary by Development Stage

Terumo Corporation, History

Terumo Corporation, Other Locations

Terumo Corporation, Subsidiaries

Terumo Corporation, Joint Venture

Terumo Corporation, Key Competitors

Terumo Corporation, Ratios based on current share price

Terumo Corporation, Annual Ratios

Terumo Corporation, Interim Ratios

Terumo Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016

Terumo Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Terumo Corporation, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Terumo Corporation Pipeline Products by Equipment Type

Terumo Corporation Pipeline Products by Development Stage

Terumo Corporation, Performance Chart (2012 - 2016)

Terumo Corporation, Ratio Charts

Terumo Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016

Terumo Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Terumo Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Note: Product cover images may vary from those shown
3 of 4

Merit Medical Systems, Inc.
Medtronic plc
Jarvik Heart, Inc.
F. Hoffmann-La Roche Ltd.
Edwards Lifesciences Corporation
Biotronik SE & Co. KG
Becton, Dickinson and Company
Bayer HealthCare AG
Abiomed, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.